CoChat

Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection

Open access
DE LA MATA, M, MEAGER, A, ROLANDO, N, DANIELS, H M, NOURI-ARIA, K T, GOKA, A K J, EDDLESTON, A L W F, ALEXANDER, G J M, WILLIAMS, R · 2008 · Clinical and Experimental Immunology
Cited by 75

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Tumour necrosis factor-alpha (TNF-α), a cytokine derived from macrophages, is considered to bean important endogenous mediator of endotoxic shock. Patients with fulminant hepatic failure are particularly susceptible to infection and the development of multi-organ failure and similarities to endotoxic shock suggest a possible pathogenetic role for TNF in fulminant hepatic failure. In vitro TNF production was therefore investigated serially in 21 consecutive patients with fulminant hepatic failure and in 21 healthy controls. Spontaneous and lipopolysaccharide-stimulated TNF production were elevated in viral-induced fulminant hepatic failure, compared with healthy controls (P < 0.05 and P <0.01, respectively). By contrast, patients with paracetamol-induced fulminant hepatic failure had normal spontaneous and lipopolysaccharide-stimulated TNF production, while those who died had significantly reduced spontaneous TNF production compared with survivors (P < 0.02); this difference was present throughout admission. In this group elevations in TNF production above baseline were associated with Gram-positive bacterial or fungal infection but not Gram-negative bacterial infection. There was no correlation between any of the clinical complications of fulminant hepatic failure and TNF production. These studies indicate that TNF is produced in response to microbial stimuli in fulminant hepatic failure, but do not support a direct role for TNF in the evolution of the clinical complications of fulminant hepatic failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2249.1990.tb05475.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 75

Metadata

Authors
DE LA MATA, M., MEAGER, A., ROLANDO, N., DANIELS, H. M., NOURI-ARIA, K. T., GOKA, A. K. J., EDDLESTON, A. L. W. F., ALEXANDER, G. J. M., & WILLIAMS, R.
Venue
Clinical and Experimental Immunology
Published
1990-12
Volume
82
Issue
3
Pages
479-484
ISSN
  • 0009-9104 (ISSN-L)
  • 1365-2249
OpenAlex
W2097880977
Cited by
75
References
3
FWCI
0.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. https://app.cochat.ai/papers/10.1111/j.1365-2249.1990.tb05475.x
The paper
DE LA MATA, M., MEAGER, A., ROLANDO, N., DANIELS, H. M., NOURI-ARIA, K. T., GOKA, A. K. J., EDDLESTON, A. L. W. F., ALEXANDER, G. J. M., & WILLIAMS, R. (2008). Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clinical and Experimental Immunology. https://doi.org/10.1111/j.1365-2249.1990.tb05475.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.